Atlas · Symbols · Stocks & Shares · DDS
Equity · United States

DILLARD'S, INC. DDS

DILLARD'S, INC. is a retail-department stores issuer listed as DDS on NYSE. This free Atlas page links SEC CIK 28917, Nasdaq Trader and TradingView NYSE:DDS, related symbols and the workstation route before a full report is run.

At a glance

DDS public profile

Business

Retail-department stores issuer. Atlas tracks DDS through its NYSE listing record, chart route and source links.

Listing

DDS trades on NYSE. SEC CIK 28917. Chart route NYSE:DDS.

Browse

Nasdaq Trader is the listing identity source for DILLARD'S, INC.. Atlas files DDS under USA Stocks for browsing. The canonical public URL is /stocks/DDS/. The workstation link below opens the fuller research run.

Market Wit preview

Dillard's comes into the day with a department store story that is refreshingly unfashionable in the best possible way: one store format, under the Dillard's name, selling the same general mix of merchandise to similar customers across its stores. Markets often prefer to describe retail as a grand puzzle of channels, journeys and other expensive nouns, but this filing rail says the core mechanism is simpler. The company runs stores, recognises customer revenue, and then leaves readers to decide whether a quieter retail machine is more interesting than the usual reinvention sermon. The latest 10-Q puts hard numbers under that plain shop-floor model, including $1.57B of revenue from contracts with customers for the period ending 2026-05-02. That is not...

Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for DDS.

Run full research Go Atlas Pro

Daily answer

What changed for DILLARD'S, INC. today

Open full report
DDS daily contextvalidated public digest18 source rail2026-06-19 06:47 UTC

Dillard’s latest daily file is led by SEC filing trail rather than market theatre. The central development is the 2026-06-05 10-Q, followed by same-day Form 4 filings, a Rule 144 notice, the SEC filing index and submissions rail, then a 2026-06-09 11-K for the Dillard’s, Inc. Investment and Employee Stock Ownership Plan. The strongest fact is simple: the latest available filed financials show $1.57B of revenue from contracts with customers, excluding assessed tax, for the 10-Q period ending 2026-05-02.

The operating story is a retailer with a plain model, not a mysterious platform. The supplied 10-Q evidence says Dillard’s operates one store format under the Dillard’s name, with each store offering the same general mix of merchandise with similar categories and similar customers. That matters because the source rail points readers back to merchandise, stores, customers and contract revenue, rather than letting the report drift into vague talk about retail sentiment.

The filed numbers give the day its weight. For the 10-Q period ending 2026-05-02, Dillard’s reported Revenues of $1.59B, Net Income Attributable to Parent of $250.6M, Assets of $4.14B, Stockholders’ Equity Attributable to Parent of $2.03B, Cash and Cash Equivalents of $1.16B, Net Cash Provided by Operating Activities of $364.0M, Payments to Acquire Property, Plant, and Equipment of $17.2M, diluted EPS of $16.04 and diluted weighted average shares outstanding of 15.6M shares.

The supplied source list does not include a chart route, quoted share price, volume, support level, resistance level or technical indicator. The market mechanism available here is therefore the public filing trail: the 10-Q financials, the Form 4 filings, the Rule 144 notice, the 11-K plan filing, the SEC filing index, the submissions JSON and the companyfacts JSON. That is a narrower rail than a full market tape, but it is cleaner than inventing candles nobody supplied.

The 10-Q also gives a product and accounting link rather than a detached earnings table. It says the company recorded $22.7M of revenue during the three months ended 2026-05-02 that had previously sat in retail operations contract liability balances of $78.4M at 2026-01-31. It also recorded $3.7M of revenue that had previously been included in billings in excess of costs and estimated earnings on uncompleted contracts of $4.5M. Those details matter because they show the filed revenue rail moving through customer obligations and contract balances, not just a headline sales number.

What remains unproven is just as important. The evidence does not supply current share-price action, same-store sales, margin detail, inventory figures, guidance, dividend policy, buyback activity, traffic data, online sales mix or management commentary beyond the named filings. A deeper file would need those source-backed items before making a fuller claim about operating momentum or market mood. For now, the report can say Dillard’s latest public record is financially specific, filing-heavy and grounded in one-store-format retail reality.

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
DDS
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView
Source authority

DDS evidence rails

Atlas uses the specific public rails available for DDS: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify evidence routes and tools; no partnership, sponsorship or endorsement is implied.

TradingView chart NYSE:DDS

Atlas has no approved static OHLC cache attached for DDS yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.

Open full TradingView chart ->

Run an Atlas research workflow on DDS

FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.

Open Atlas workstation ->
Atlas Pro

Save DDS research and exports

Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

DDS FAQ

What is DILLARD'S, INC. (DDS)?DILLARD'S, INC. is a retail-department stores issuer listed as DDS on NYSE. This free Atlas page links SEC CIK 28917, Nasdaq Trader and TradingView NYSE:DDS, related...

DILLARD'S, INC. is a retail-department stores issuer listed as DDS on NYSE. This free Atlas page links SEC CIK 28917, Nasdaq Trader and TradingView NYSE:DDS, related symbols and the workstation route before a full report is run.

What does Atlas show for DDS?The DDS page gives the free Atlas profile for DILLARD'S, INC.: listing identity, chart route, related symbols, source authority and the workstation route. The chart...

The DDS page gives the free Atlas profile for DILLARD'S, INC.: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:DDS; the stable page route is /stocks/DDS/. Visible source links include SEC EDGAR CIK 28917, Nasdaq Trader and TradingView NYSE:DDS. Atlas files DDS under USA Stocks for browsing.

How often is the DDS page updated?The /stocks/DDS/ URL is stable. Atlas updates the free DDS page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...

The /stocks/DDS/ URL is stable. Atlas updates the free DDS page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.

Which sources does Atlas use for DDS?For DDS, Atlas starts with SEC EDGAR CIK 28917, Nasdaq Trader and TradingView NYSE:DDS. The SEC CIK 28917 route is the issuer filing anchor. Nasdaq Trader confirms the...

For DDS, Atlas starts with SEC EDGAR CIK 28917, Nasdaq Trader and TradingView NYSE:DDS. The SEC CIK 28917 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:DDS is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.

Can Atlas run a full research brief on DDS?Yes. The workstation can open DDS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open DDS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this DDS page investment advice?No. The DDS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...

No. The DDS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-06-19. Browse FreedomCore Atlas research notes →